We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
81 hedge funds and large institutions have $69.1M invested in Invesco Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
19% more capital invested
Capital invested by funds: $58.2M → $69.1M (+$10.9M)
12% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 17
4.02% more ownership
Funds ownership: 18.9% → 22.92% (+4%)
3% more funds holding
Funds holding: 79 → 81 (+2)
Holders
81
Holders Change
+2
Holders Change %
+2.53%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
17
Closed
7
Calls
$221K
Puts
–
Net Calls
+$221K
Net Calls Change
+$221K
Top Buyers
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$8.67M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.47M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.17M |
| 4 |
Morgan Stanley
New York
|
+$833K |
| 5 |
Goldman Sachs
New York
|
+$706K |
